Express Pharma
Home  »  Latest Updates  »  Lupin receives FDA approval for generic Seroquel XR tabs

Lupin receives FDA approval for generic Seroquel XR tabs

12
Read Article

The drug is indicated for the treatment of schizophrenia

Lupin has received final approval for its Quetiapine Fumarate extended-release tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg from the USFDA to market a generic version of AstraZeneca Pharmaceuticals LP’s Seroquel XR tablets 50 mg, 150 mg, 200 mg, 300 mg and 400 mg.

Lupin’s Quetiapine Fumarate extended-release tablet is indicated for the treatment of schizophrenia; acute manic or mixed episodes in bipolar I disorder alone or as an adjunct to lithium or divalproex; acute depressive episodes in bipolar disorder; maintenance treatment of bipolar I disorder, as an adjunct to lithium or divalproex and as an adjunctive therapy to antidepressants for the treatment of major depressive disorder.

Comments are closed.